Geode Capital Management, LLC Athira Pharma, Inc. Transaction History

Geode Capital Management, LLC

$1.39 Trillion
Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 305,964 shares of ATHA stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

305,964

Previous 311,498 1.78%

Holding current value

$1.28 Million

Previous $87,000 4.6%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$0.23 - $0.36 $1,272 - $1,992	-5,534 Reduced 1.78%	305,964 $91,000
Q1 2025 May 13, 2025	SELL	$0.28 - $0.59 $2,616 - $5,514	-9,346 Reduced 2.91%	311,498 $87,000
Q3 2024 Nov 12, 2024	BUY	$0.42 - $3.43 $5,736 - $46,850	13,659 Added 4.45%	320,844 $144,000
Q2 2024 Aug 09, 2024	BUY	$1.92 - $2.71 $13,340 - $18,829	6,948 Added 2.31%	307,185 $814,000
Q1 2024 May 13, 2024	BUY	$2.24 - $4.15 $37,878 - $70,176	16,910 Added 5.97%	300,237 $822,000
Q3 2023 Nov 13, 2023	SELL	$1.9 - $3.16 $19,389 - $32,247	-10,205 Reduced 3.48%	283,327 $572,000
Q2 2023 Aug 11, 2023	SELL	$2.36 - $3.59 $799,605 - $1.22 Million	-338,816 Reduced 53.58%	293,532 $865,000
Q1 2023 May 15, 2023	BUY	$2.26 - $4.22 $67,336 - $125,734	29,795 Added 4.94%	632,348 $1.58 Million
Q4 2022 Feb 13, 2023	BUY	$2.76 - $3.71 $27,183 - $36,539	9,849 Added 1.66%	602,553 $1.91 Million
Q3 2022 Nov 14, 2022	BUY	$2.93 - $3.96 $52,045 - $70,341	17,763 Added 3.09%	592,704 $1.76 Million
Q2 2022 Aug 12, 2022	BUY	$2.74 - $13.43 $32,616 - $159,870	11,904 Added 2.11%	574,941 $1.75 Million
Q1 2022 May 13, 2022	BUY	$8.96 - $13.51 $31,691 - $47,784	3,537 Added 0.63%	563,037 $7.6 Million
Q4 2021 Feb 11, 2022	BUY	$9.17 - $16.39 $1.59 Million - $2.85 Million	173,752 Added 45.04%	559,500 $7.29 Million
Q3 2021 Nov 12, 2021	SELL	$9.15 - $11.09 $224,559 - $272,170	-24,542 Reduced 5.98%	385,748 $3.62 Million
Q2 2021 Aug 13, 2021	BUY	$10.24 - $20.87 $1.66 Million - $3.38 Million	161,729 Added 65.07%	410,290 $4.2 Million
Q1 2021 May 12, 2021	BUY	$16.9 - $29.77 $485,165 - $854,637	28,708 Added 13.06%	248,561 $4.57 Million
Q4 2020 Feb 12, 2021	BUY	$16.48 - $34.3 $3.62 Million - $7.54 Million	219,853 New	219,853 $7.53 Million

Others Institutions Holding ATHA

# of Institutions

Shares Held

16.9M

Call Options Held

24.1K

Put Options Held

View Full List

About Athira Pharma, Inc.

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $158M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

More about ATHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Athira Pharma, Inc. Transaction History